LFMD LifeMD, Inc.

LifeMD (formerly Conversion Labs) is a rapidly growing direct to consumer telemedicine and wellness company. In addition to our proven online marketing expertise, we have built a technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications directly to patients in all 50 states. We believe telemedicine will transform the American healthcare system by increasing access to care and improving outcomes. We’re proud to be a leader in this rapidly evolving space.

$2.13
As of 05/24/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Pharmaceutical Retailers
Index country:  USA
Country of incorporation:  USA
IPO date:  07/11/2001
Outstanding shares:  30,796,429
Average volume:  140,701
Market cap:   $63,132,679
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -1.05
PB ratio:   5.09
PS ratio:   0.61
Return on equity:   -481.00%
Net income %:   -61.10%